Accueil

: |

International

Belgique
Česká republika
Deutschland
España
France
Italia
Nederland
Österreich
Portugal
Slovensko
Switzerland
United Kingdom
USA

Stallergenes Group
Email alert
Contact

|

About Stallergenes
Stallergenes share
Shareholder area
Results
Publications
News

Publications

2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002

2008

Annual reports

See

Annual repport

Download

Half-yearly report

See

Half-year report

Download

Press releases

See

Launch of a ph.III clinical trial in adults for Oralair Grasses in the US

Download
Quarterly information: Continuing growth dynamics

Download
Partnership with Catalent and The Medical House

Download
Stallergenes inaugurates the biggest pharmaceutical allergene production un...

Download
Oralair® Grasses 300 IR : Highly positive results in a pharmacodynamic stud...

Download
First Half Year 2008: a 19% increase in operating profit and net profit

Download
Q2 2008 sales up 18%

Download
Implementation of a liquidity contract

Download
Obtention of the market authorization in Germany for Oralair® Grasses

Download
2008 1st quarter sales up 15%

Download
2007 results

Download
Quarterly information

Download

Liquidity contracts

See

June 30th

Download
December 31th

Download

Statements of voting rights

See

January 31th

Download
February 29th

Download
March 31th

Download
April 30th

Download
May 30th

Download
June 30th

Download
July 31th

Download
August 29th

Download
October 31th

Download
September 30th

Download
November 30th

Download
December 31th

Download

logo3 Sitemap | Legal | Credits
Belgique | Česká republika | Deutschland | España | France | Italia | Nederland | Österreich | Portugal | Slovensko | Switzerland | United Kingdom | USA